Boehringer plans new filings for Giotrif in lung cancer

… a subgroup of non-small cell lung cancer (NSCLC), the most common form … , however, and this type of lung cancer is associated with a particularly … crowded EGFR inhibitor marketplace in lung cancer. In addition to Tarceva it … Vargatef (nintedanib), another drug for lung cancer approved last year. Please enable …